Kwang-Su Park

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Venues

Journal of medicinal chemistry

Research square

Nature reviews. Cancer

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Velez, Yulin Han, Hyerin Yim, Peiyi Yang, Zhijie Deng, Kwang-Su Park, Md Kabir, H Ümit Kaniskan, Yan Xiong, Jian Jin
Discovery of the First-in-Class G9a/GLP PROTAC Degrader. Journal of medicinal chemistry (2024)
Md Kabir, Lihuai Qin, Kaixiu Luo, Yan Xiong, Rebecca A Sidi, Kwang-Su Park, Jian Jin
Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader. Journal of medicinal chemistry 67 (8) (2024)
Julia Velez, Yulin Han, Hyerin Yim, Peiyi Yang, Zhijie Deng, Kwang-Su Park, Md Kabir, H Ümit Kaniskan, Yan Xiong, Jian Jin
Discovery of the First-in-Class G9a/GLP PROTAC Degrader. Journal of medicinal chemistry 67 (8) (2024)
Md Kabir, Lihuai Qin, Kaixiu Luo, Yan Xiong, Rebecca A Sidi, Kwang-Su Park, Jian Jin
Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader. Journal of medicinal chemistry (2024)
Md Kabir, Lihuai Qin, Kaixiu Luo, Yan Xiong, Rebecca A Sidi, Kwang-Su Park, Jian Jin
Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader. Journal of medicinal chemistry 67 (8) (2024)
Julia Velez, Yulin Han, Hyerin Yim, Peiyi Yang, Zhijie Deng, Kwang-Su Park, Md Kabir, H Ümit Kaniskan, Yan Xiong, Jian Jin
Discovery of the First-in-Class G9a/GLP PROTAC Degrader. Journal of medicinal chemistry (2024)
Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Kwang-Su Park, Vincent Fagan, Fengling Li, Irene Chau, Masoud Vedadi, Cheryl H Arrowsmith, Paul Brennan, Oleg Fedorov, Manfred Jung, Gillian Farnie, Jing Liu, Udo Oppermann, Roland Schüle, Jian Jin
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of medicinal chemistry 67 (7) (2024)
Julia Velez, Yulin Han, Hyerin Yim, Peiyi Yang, Zhijie Deng, Kwang-Su Park, Md Kabir, H Ümit Kaniskan, Yan Xiong, Jian Jin
Discovery of the First-in-Class G9a/GLP PROTAC Degrader. Journal of medicinal chemistry 67 (8) (2024)
Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Kwang-Su Park, Vincent Fagan, Fengling Li, Irene Chau, Masoud Vedadi, Cheryl H Arrowsmith, Paul Brennan, Oleg Fedorov, Manfred Jung, Gillian Farnie, Jing Liu, Udo Oppermann, Roland Schüle, Jian Jin
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of medicinal chemistry 67 (7) (2024)
Julia Velez, Yulin Han, Hyerin Yim, Peiyi Yang, Zhijie Deng, Kwang-Su Park, Md Kabir, H Ümit Kaniskan, Yan Xiong, Jian Jin
Discovery of the First-in-Class G9a/GLP PROTAC Degrader. Journal of medicinal chemistry 67 (8) (2024)
Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Kwang-Su Park, Vincent Fagan, Fengling Li, Irene Chau, Masoud Vedadi, Cheryl H Arrowsmith, Paul Brennan, Oleg Fedorov, Manfred Jung, Gillian Farnie, Jing Liu, Udo Oppermann, Roland Schüle, Jian Jin
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of medicinal chemistry (2024)
Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Kwang-Su Park, Vincent Fagan, Fengling Li, Irene Chau, Masoud Vedadi, Cheryl H Arrowsmith, Paul Brennan, Oleg Fedorov, Manfred Jung, Gillian Farnie, Jing Liu, Udo Oppermann, Roland Schüle, Jian Jin
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of medicinal chemistry 67 (7) (2024)
Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Kwang-Su Park, Vincent Fagan, Fengling Li, Irene Chau, Masoud Vedadi, Cheryl H Arrowsmith, Paul Brennan, Oleg Fedorov, Manfred Jung, Gillian Farnie, Jing Liu, Udo Oppermann, Roland Schüle, Jian Jin
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of medicinal chemistry 67 (7) (2024)
Kwang-Su Park, Lihuai Qin, Md Kabir, Kaixiu Luo, Brandon Dale, Yue Zhong, Arum Kim, Gang Greg Wang, Husnu Ümit Kaniskan, Jian Jin
Targeted Degradation of PRC1 Components, BMI1 and RING1B, via a Novel Protein Complex Degrader Strategy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Xian Chen, Ling Xie, Ryan N Sheehy, Yan Xiong, Adil Muneer, John A Wrobel, Kwang-Su Park, Jing Liu, Julia Velez, Yanjia Luo, Ya-Dong Li, Luis Quintanilla, Yongyi Li, Chongchong Xu, Zhexing Wen, Juan Song, Jian Jin, Mohanish Deshmukh
Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer's disease proteopathology for precision medication. Research square (2023)
Xufen Yu, Dongxu Li, Jithesh Kottur, Yudao Shen, Huen Suk Kim, Kwang-Su Park, Yi-Hsuan Tsai, Weida Gong, Jun Wang, Kyogo Suzuki, Joel S Parker, Laura E Herring, Husnu Ümit Kaniskan, Ling Cai, Rinku Jain, Jing Liu, Aneel K Aggarwal, Gang Greg Wang, Jian Jin
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Science translational medicine 13 (613) (2021)
Brandon Dale, Meng Cheng, Kwang-Su Park, Husnu Ümit Kaniskan, Yue Xiong, Jian Jin
Advancing targeted protein degradation for cancer therapy. Nature reviews. Cancer 21 (10) (2021)
Chiara Luise, Dina Robaa, Pierre Regenass, David Maurer, Dmytro Ostrovskyi, Ludwig Seifert, Johannes Bacher, Teresa Burgahn, Tobias Wagner, Johannes Seitz, Holger Greschik, Kwang-Su Park, Yan Xiong, Jian Jin, Roland Schüle, Bernhard Breit, Manfred Jung, Wolfgang Sippl
Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 Inhibitors. International journal of molecular sciences 22 (11) (2021)

Kwang-Su Park.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kwang-Su Park